SARS-CoV-2 show no infectivity at later stages in a prolonged COVID-19 patient despite positivity in RNA testing
Xiu-Feng Wan, Cynthia Y. Tang, Detlef Ritter, Yang Wang, Tao Li, Karen Segovia, Martina Kosikova, Marc Johnson, Hyung Joon Kwon, Hang Xie, Richard D. Hammer, Jane A. McElroy, Aws Hamid, Natalie D Collins, Jun Hang, Simone Camp
doi: https://doi.org/10.1101/2021.03.18.21253228
Xiu-Feng Wan
1MU Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, Missouri, USA
2Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA
3Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA
4Department of Electrical Engineering & Computer Science, College of Engineering, University of Missouri, Columbia, Missouri, USA
5MU Institute for Data Science and Informatics, University of Missouri, Columbia, Missouri, USA
Cynthia Y. Tang
1MU Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, Missouri, USA
2Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA
3Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA
5MU Institute for Data Science and Informatics, University of Missouri, Columbia, Missouri, USA
Detlef Ritter
6Department of Pathology, University of Missouri, Columbia, Missouri, USA
Yang Wang
1MU Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, Missouri, USA
2Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA
3Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA
5MU Institute for Data Science and Informatics, University of Missouri, Columbia, Missouri, USA
Tao Li
7Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA
Karen Segovia
1MU Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, Missouri, USA
2Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA
3Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA
5MU Institute for Data Science and Informatics, University of Missouri, Columbia, Missouri, USA
Martina Kosikova
8Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA
Marc Johnson
2Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA
Hyung Joon Kwon
8Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA
Hang Xie
8Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA
Richard D. Hammer
6Department of Pathology, University of Missouri, Columbia, Missouri, USA
Jane A. McElroy
9Department of Family Medicine, School of Medicine, University of Missouri, Columbia, Missouri, USA
Aws Hamid
10Department of Radiology, School of Medicine, University of Missouri, Columbia, Missouri, USA
Natalie D Collins
7Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA
Jun Hang
7Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA
Simone Camp
6Department of Pathology, University of Missouri, Columbia, Missouri, USA

Article usage
Posted March 20, 2021.
SARS-CoV-2 show no infectivity at later stages in a prolonged COVID-19 patient despite positivity in RNA testing
Xiu-Feng Wan, Cynthia Y. Tang, Detlef Ritter, Yang Wang, Tao Li, Karen Segovia, Martina Kosikova, Marc Johnson, Hyung Joon Kwon, Hang Xie, Richard D. Hammer, Jane A. McElroy, Aws Hamid, Natalie D Collins, Jun Hang, Simone Camp
medRxiv 2021.03.18.21253228; doi: https://doi.org/10.1101/2021.03.18.21253228
SARS-CoV-2 show no infectivity at later stages in a prolonged COVID-19 patient despite positivity in RNA testing
Xiu-Feng Wan, Cynthia Y. Tang, Detlef Ritter, Yang Wang, Tao Li, Karen Segovia, Martina Kosikova, Marc Johnson, Hyung Joon Kwon, Hang Xie, Richard D. Hammer, Jane A. McElroy, Aws Hamid, Natalie D Collins, Jun Hang, Simone Camp
medRxiv 2021.03.18.21253228; doi: https://doi.org/10.1101/2021.03.18.21253228
Subject Area
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (728)
- Anesthesia (215)
- Cardiovascular Medicine (3126)
- Dermatology (265)
- Emergency Medicine (464)
- Epidemiology (13076)
- Forensic Medicine (14)
- Gastroenterology (868)
- Genetic and Genomic Medicine (4895)
- Geriatric Medicine (451)
- Health Economics (755)
- Health Informatics (3089)
- Health Policy (1109)
- Hematology (411)
- HIV/AIDS (973)
- Medical Education (457)
- Medical Ethics (121)
- Nephrology (502)
- Neurology (4664)
- Nursing (248)
- Nutrition (691)
- Oncology (2405)
- Ophthalmology (683)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (311)
- Palliative Medicine (88)
- Pathology (519)
- Pediatrics (1249)
- Primary Care Research (526)
- Public and Global Health (7231)
- Radiology and Imaging (1613)
- Respiratory Medicine (945)
- Rheumatology (462)
- Sports Medicine (403)
- Surgery (518)
- Toxicology (65)
- Transplantation (222)
- Urology (193)